Collectively, this study establishes a ROS-scavenging and AhR-activating nanodelivery system that achieves a "one-stone-three-birds" outcome-attenuating inflammation, repairing mucosa, and rebalancing microbiota-providing new experimental evidence and theoretical support for ulcerative colitis therapy. Here, AHR is linked to ulcerative colitis.